Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: A population-based nested case-control study

Journal of Clinical Psychiatry

Volumn 71, Issue 2, 2010, Pages 103-108

  Baandrup, Lone ^a   Gasse, Christiane ^b   Jensen, Vibeke D ^c   Glenthoj, Birte Y ^a   Nordentoft, Merete ^d   Lublin, Henrik ^a   Fink Jensen, Anders ^e   Lindhardt, Anne ^e   Mortensen, Preben B ^b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c DANISH MEDICINES AGENCY   (Denmark)

^d Mental Health Services CPH   (Denmark)

^e Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CAUSE OF DEATH; CONTROLLED STUDY; DEATH; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CASE-CONTROL STUDIES; CAUSE OF DEATH; DENMARK; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SCHIZOPHRENIA;

EID: 77649122136     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m04818yel     Document Type: Article

References (30)

1. Ganguly R, Kotzan JA, Miller LS, et al. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000. J Clin Psychiatry. 2004;65: 1377-1388.
2. McCue RE, Waheed R, Urcuyo L. Polypharmacy in patients with schizophrenia. J Clin Psychiatry. 2003;64:984-989.
3. Clark RE, Bartels SJ, Mellman TA, et al. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy. Schizophr Bull. 2002;28:75-84.
4. Miller AL, Craig CS. Combination antipsychotics: pros, cons and questions. Schizophr Bull. 2002;28:105-109.
5. Stahl SM, Grady MM. A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. Curr Med Chem. 2004;11:313-327.
6. Moore TA, Buchanan RW, Buckley PF, et al. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. J Clin Psychiatry. 2007;68:1751-1762.
7. Auquier P, Lançon C, Rouillon F, et al. Mortality in schizophrenia. Pharmacoepidemiol Drug Saf. 2006;15:873-879.
8. Brown S. Excess mortality of schizophrenia: a meta-analysis. Br J Psychiatry. 1997;171:502-508.
9. Jeste DV, Gladsjo JA, Lindamer LA, et al. Medical comorbidity in schizophrenia. Schizophr Bull. 1996;22:413-430.
10. Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry. 1998;173:11-53.
11. Andersen TF, Madsen M, Jørgensen J, et al. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
12. Pedersen CB, Gøtzsche H, Møller JO, et al. The Danish civil registration system: a cohort of eight million persons. Dan Med Bull. 2006;53: 441-449.
13. Regier DA, Farmer M, Rae D, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiologic catchment area (ECA) study. JAMA. 1990;264:2511-2518.
14. Gaitatzis A, Trimble M, Sander J. The psychiatric comorbidity of epilepsy. Acta Neurol Scand. 2004;110:207-220.
15. Paykel ES, Abbott R, Jenkins R, et al. Urban-rural mental health differences in Great Britain: findings from the national morbidity survey. Psychol Med. 2000;30:269-280.
16. Montout C, Casadebaig F, Lagnaoui R, et al. Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients. Schizophr Res. 2002;57:147-156.
17. Morgan MG, Scully PJ, Youssef HA, et al. Prospective analysis of premature mortality in schizophrenia in relation to health service engagement: a 7.5-year study within an epidemiologically complete, homogeneous population in rural Ireland. Psychiatry Res. 2003;117:127-135.
18. Joukamaa M, Heliövaara M, Knekt P, et al. Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry. 2006;188:122-127.
19. Waddington JL, Youssef HA, Kinsella A. Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. Br J Psychiatry. 1998;173: 325-329.
20. Hollis J, Touyz S, Grayson D, et al. Antipsychotic medication dispensing and associated odds ratio of death in elderly veterans and war widows, 2001. Aust N Z J Psychiatry. 2006;40:981-986.
21. Gillies D, Beck A, McCloud A, et al. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. Cochrane Database Syst Rev. 2005;4:CD003079.
22. Volz A, Khorsand V, Gillies D, et al. Benzodiazepines for schizophrenia. Cochrane Database Syst Rev. 2007;1:CD006391.
23. Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154:854-864.
24. Phelan M, Stradins L, Morrison S. Physical health of people with severe mental illness. BMJ. 2001;322:443-444.
25. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential gap worsening over time? Arch Gen Psychiatry. 2007;64:1123-1131.
26. Hansen SS, Munk-Jørgensen P, Guldbæk B, et al. Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand. 2000; 102:432-438.
27. Suissa S. Immeasurable time bias in observational studies of drug effects on mortality. Am J Epidemiol. 2008;168:329-335.
28. Royal College of Psychiatrists. Report of the Working Group of the Royal College of Psychiatrists', Psychopharmacology sub-group: the association between antipsychotic drugs and sudden death. Council Report, CR57. http://www.rcpsych.ac.uk/files/pdfversion/cr57.pdf. London: Royal College of Psychiatrists; 1997.
29. Mortensen PB, Juel K. Mortality and causes of death in schizophrenic patients in Denmark. Acta Psychiatr Scand. 1990;81:372-377.
30. The Danish national drug interaction database. http://www. interaktionsdatabasen.dk, Accessed July 1, 2008.